DCOYVSLABT• 12 Months (Normalized)
DCOY vs LABT (Decoy Therapeutics Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Oct 1, 2025 to Oct 1, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DCOY Performance $1.97
-95.68%
Decoy Therapeutics Inc.
Normalized Baseline0.00%
LABT Performance $0.99
+%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin LABT LEADS
-95.68 pts
LABT outperforming by 95.68 percentage points
DCOYLABT
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DCOY LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | DCOY Price | DCOY Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 30, 2026 | $1.97 | -95.68% | $- | - | |
| Sep 29, 2026 | $2.13 | -95.33% | $0.99 | -98.86% | +3.53% |
| Sep 28, 2026 | $2.31 | -94.93% | $1.15 | -98.67% | +3.74% |
| Sep 25, 2026 | $3.09 | -93.22% | $1.67 | -98.07% | +4.85% |
| Sep 24, 2026 | $3.11 | -93.18% | $1.83 | -97.88% | +4.70% |
| Sep 23, 2026 | $3.85 | -91.56% | $1.78 | -97.94% | +6.38% |
| Sep 22, 2026 | $3.10 | -93.20% | $1.99 | -97.70% | +4.50% |
| Sep 21, 2026 | $2.56 | -94.39% | $2.05 | -97.63% | +3.24% |
| Sep 18, 2026 | $2.78 | -93.90% | $1.99 | -97.70% | +3.80% |
| Sep 17, 2026 | $2.83 | -93.79% | $1.86 | -97.85% | +4.06% |
| Sep 16, 2026 | $2.89 | -93.66% | $2.09 | -97.58% | +3.92% |
| Sep 15, 2026 | $2.71 | -94.06% | $2.17 | -97.49% | +3.43% |
| Sep 14, 2026 | $2.71 | -94.06% | $2.12 | -97.55% | +3.49% |
| Sep 11, 2026 | $2.67 | -94.14% | $2.22 | -97.43% | +3.29% |
| Sep 10, 2026 | $2.73 | -94.01% | $2.05 | -97.63% | +3.62% |
Page 1 of 17